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They used Case Identification Schedule as an assessment
tool in the study. Venkataswamy Reddy and Chandrashekar
(1998) conducted a meta-analysis of 13 psychiatric
epidemiological studies consisting of 33572 persons in 6550
families which yielded an estimate prevalence rate of 58.2
per thousand populations. A prevalence of 2.7 for
schizophrenia was found. Authors concluded that in the
selected studies no significant difference of prevalence w.r.t.
sex and locality could be found. Ganguli (2000), reviewed
major epidemiological studies in the last four decades came
out with a national prevalence rate of 2.5 per 1000. He
also concluded that schizophrenia is the only disorder whose
prevalence is consistent across cultures and over time
B.  Incidence studies
Incidence studies are few in number. It is due to absence
of demarcated catchment areas for health service delivery,
lack of case registers and cost effectiveness of studies. In
3 incidence studies, rates have varied from 3.5 - 4.7 per
10,000. As a part of WHO collaborative study on
Determinants of Outcome of Specific Mental Disorders,
overall incidence was reported to be 4.4 per 10,000 in rural
and 3.8 per 10,000 in urban areas of Chandigarh (Wig et
al., 1993). In an ICMR study carried out by Rajkumar et
al., (1993), incidence of schizophrenia was studied in
Madras using ICD-10, PSE and IPSS criteria. An incidence
rate of 3.5 per 10,000 was reported. No male -female
differences were found.
C. Limitation of epidemiological studies:
Epidemiological work in India, so far has focused only on
frequency of illness and other wide variety of associated
factors have not been researched. No large-scale socio -
demographic analysis on factors such as social class, religion,
communities have been carried out.
III.  Psychopathology, sub-syndromes and diagnosis
Issues of psychopathology, sub-syndromes and diagnosis
have been addressed to a limited extent in the last decade.
A. Psychopathology:
In earlier studies done in the Indian settings on this subject,
it has been brought out that psychopathology of Indian
patients of schizophrenia differs from that of Western
patients and is coloured by the culture. Kulhara et al., (2000)
in this context suggested the occurrence of sub cultural
delusions and hallucinations in Indian patients, though the
same is declining.
Jaydeokar et al., (1997) determined the prevalence of OC
symptoms among chronic schizophrenic patients. 101
patients satisfying DSM-IV diagnosis of chronic
schizophrenia were assessed for OC symptoms. All patients
were also rated on the Yale-Brown Obsessive Compulsive
Scale for the severity of their symptoms. The study revealed
that 26.7% of the chronic schizophrenic patients had
significant OC symptoms with a high prevalence in the age
group below 35 years. OC symptoms were more severe in
patients with duration of illness more than 5 years. The OC
symptoms were more prevalent among paranoid
schizophrenics with the frequent obsessions being that of
contamination, sexual and aggressive thoughts and frequent
compulsion was need to ask or confess.
Comparing phenomenology of early versus late onset
schizophrenia, Harrish et al., (1996) in a retrospective chart
analysis studied 59 patients of schizophrenia with an age of
onset more than 45 years. Persecutory delusions were
commonest, followed by delusions of influence. 53% had
third person type hallucinations. 42% had negative
symptoms. There was no delusional perception or thought
echo. In a comparative study, Kulhara et al., (1999) found
that late onset schizophrenia was different from early onset
primarily on “persecutory delusion”.
Jiloha et al., (1998) reported a case of a female patient
with schizophrenia who developed delusion that she was a
male and behaved and dressed like a male. She developed
intimacy with another girl and wanted to marry her. The
patient responded to effective treatment of schizophrenia
B. Sub-syndromes
Sub typing and delineation of various sub syndromes of
schizophrenia using multivariate analysis have been the
focus of research in this decade. Indian researchers have
mainly concentrated their work on positive and negative
subtypes of schizophrenia. Arora et al., (1997) reported
about syndromic manifestations of schizophrenia and
demonstrated the applicability of this concept to India. It
was also shown that negative symptoms have stability over
period of time, though factor structure of positive/negative
subtype changed over time. Another important finding is
delineation of “thought disordered” sub syndrome and the
need to state more than two factors (Kulhara, 1997).
Post psychotic depression, depressive symptoms in
schizophrenia, distinction between depressive and negative
symptoms in schizophrenia too have been researched
(Kulhara & Avasthi, 1993). Avasthi (1997) reviewed this
topic and elaborated that depressive symptoms do occur in
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schizophrenia in India to the same extent as in West.
Repeated hospitalization, a variable associated with
depression in West is not much important in India
(Chintalpudi et al., 1993). Also, there has been mention of
retaining the concept of “simple schizophrenia” (Singh and
Kulhara, 1991).
Shrivastva and Rao (1999) studied seventy-six first episode,
drug naive patients of schizoaffective disorder, diagnosed
as per DSM-III-R criteria. They were followed up over a
period of two years in order to verify the consistency of
diagnosis. It was observed that only in 14 (18.4%) patients
diagnosis did not change over a period of two years. In the
majority of the patients (47, 61.9%) the diagnosis changed
to schizophrenia. Eight patients (10.5%) had only depressive
symptoms during the subsequent episodes and they satisfied
the diagnostic criteria for major depression. While 7 (9.2%)
patients remained symptom free over the study period, so
diagnosis of schizoaffecive disorder could not be
reconfirmed. Authors cautioned against the diagnosis of
schizoaffective disorder early in course of illness.
C. Insight
In various studies on insight in schizophrenia, insight was
found to be negatively correlated with psychopathology and
only partially dependent on psychopathology (Aga et al.,
1995; Kulhara et al., 1992). Tharyan and Saravanan (2000)
found a significant correlation of severity of
psychopathology with dimensional measures of awareness
about abnormal experiences. It was also concluded that
awareness of abnormal nature of individual items of
psychopathology does not necessarily overlap with insight
as measured by awareness of concept or consequence of
mental illness or need for treatment.
IV. Biological Research
Despite the worldwide focus, biological research on
schizophrenia in India, has remained at a primitive level. It
is primarily due to the lack of facilities, financial constraints,
lack of national register, poor awareness, associated stigma
and dearth of psychiatric centers. Despite all difficulties, in
last decade some progress has been made to study various
biological variables associated with schizophrenia, which
would be reviewed under sections of biochemical,
immunological, genetics, neuroimaging and miscellaneous.
A. Biochemical studies
From 1960 to 1990, number of biochemical and hormonal
variables such as histamine, indole, CSF-NANA levels,
homovanillic acid, 5 hydroxy indole - acidic acid (5-HIAA),
HVA level, prolactin levels, leutinising hormones and growth
hormones, VMA levels were studied in patients with
schizophrenia. In the last decade there has been dearth of
such studies. Sharma et al., (1990, 1991) reported that
platelet MAO could be specific for some categories of
schizophrenia. They reported that paranoid types had
significantly lower MAO activity than non-paranoid types.
Moreover, a premorbid schizoid personality resulted in
significant lower enzyme levels, but no correlation existed
for family history of schizophrenia and types and age of
onset of illness.
B.  Immunological studies :
Aggarwal et al., (1991) found similar baseline values of T
and B-lymphocytes count in schizophrenia, depressive and
healthy controls, which increased significantly with
antipsychotic medication.
C. Genetic studies
Genetic research in schizophrenia has concentrated mainly
on studying dermatoglyphics.
Male catatonics were reported to have more arches, loops
and less whorls, smaller angles (Jhingran & Munjal, 1990)
and higher frequency of C-absent line (Sen Gupta &
Bhuyan, 1995). Higher co-occurrence of SRBC (Single
Radial Base Crease) and TRBC (Triple Radial Base Crease)
was found in catatonic, disorganized and undifferentiated
subtypes (Jain, 1991).
D. Radio imaging studies
Due to lack of facilities, this area has received little attention.
Siddartha et al., (1997) studied Ventricular Brain Ratio,
Width of Third Ventricle (WTV), Width of Sylvian Fissure
(WSF) in schizophrenia (divided into positive, negative and
mixed types). Parameters were found to be higher in
schizophrenia than in normal controls. Positive subgroup
had smaller VBR and WTV than negative or mixed, but
larger WSF and WTV than control.
Lal et al., (1998) attempted to examine positive/negative
dichotomy of schizophrenia and its relation to
neuropsychological performance, presence of soft signs and
VBR. VBR had negative correlation with neuro-
psychological performance. It was concluded that soft signs
were consequence of damage to cerebrum and not linked
to any subtype.
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E. Miscellaneous studies
Sharan et al., (1990) found higher prevalence of Smooth
Persuit Eye Movements (SPEM) in schizophrenia than
normal controls, and attempted to examine these as a
genetic trait marker.
Borde et al., (1996) revealed right hemispheric dysfunctions
in schizophrenia as compared to normal controls on happy-
sad chimerie faces test.
Ravikumar Kurrup et al., (1999) demonstrated elevated
serum digoxin levels and elevated HMG CoA reductase
activity suggesting increased digoxin synthesis, reduced
sodium-potassium ATPase activity and altered sugar
residues of serum glycoprotein in schizophrenia. They
proposed a hypothalamic digoxin mediated model for
conscious and subliminal perception. Significance of its
dysfunction due to abnormal glycoprotein induced synaptic
connectivity defects in schizophrenia was discussed.
F. Comments on biological studies
Although the studies done in this decade have shown
improvement in areas such as selection of proper control
group, diagnostic criteria etc., still there is hardly any
research available on the structural and functional
abnormalities of the brain found in schizophrenia. Lacks of
facilities are the major reasons for this shortcoming. Better
facilities associated with creation of national register and
attempts at removal of stigma are some of the steps
suggested to improve the situation.
V. Research on Management
A. Somatic Treatment
i) Pharmacological Management
Research on pharmacological management of schizophrenia
in last decade has mainly concentrated on establishing
usefulness of various agents (mainly atypical antipsychotics)
in disorder and some attempt at defining management
guidelines (Kulhara et al., 2000).
1. Antipsychotics
Since various atypical antipsychotics were introduced in
the beginning of last decade, majority of studies have focused
on usefulness and side effects of these antipsychotics.
Research into the typical antipsychotics has taken a back
seat.
A) Clinical usefulness
Evidence for clinical usefulness comes from case reports,
case series, open trials, controlled trials and double blind
trials.
a) Open trials
Typical antipsychotics
Emmanuel et al., (1997) treated 60 patients of schizophrenia
as per DSM III-R criteria in an open, non-comparative study
with loxapine over duration of 6 weeks. The assessment of
the patients was carried out using the Positive And Negative
Syndrome Scale (PANSS) and Clinical Global Impression
(CGI) Scale. The side effects were noted on the
Extrapyramidal Rating Scale and Asberg Scale for side
effects. There was a statistically significant improvement
in all the item scores of PANSS except ‘Guilt feeling’ and
‘Depression’. A similar significant improvement was also
observed in the factor scores and cluster scores of PANSS.
On analysis, there was substantial improvement in the
negative scale ratings on PANSS in the negative subtyped
group.
Atypical antipsychotics
In an open trial, drug-resistant schizophrenics were treated
with clozapine for sixteen weeks. The patients were rated
on BPRS, PANSS, Side effects scale and Global Impression
Scale at weeks 0, 9 and 16.  Of the total 29 patients included,
25 completed the trial. The patients showed significant
improvement on both BPRS and PANSS, although the
improvement was more in initial weeks than between 9
and 16 weeks. The most common side effects observed
were sedation, hypersalivation and tachycardia (Aggarwal
et al., 1997). Desai et al., (1999) also reported usefulness
of clozapine in reduction of scores on BPRS and PANSS
in treatment resistant schizophrenia. Risperidone also has
been reported to be useful in reduction in both positive and
negative symptoms in treatment resistant, treatment
intolerant, drug naïve and chronic schizophrenia (  Bajaj P
et al., 1999; Aggarwal et al., 1998; Agashe et al.,
1999).Suresh Kumar (1999) conducted an open clinical trial
of risperidone (6-8 mg/day) on a group of DSM-IV defined
24 drug naive schizophrenic population for a period of 12
weeks. Risperidone showed significant improvement in their
positive, negative, general psychopathology and depressive
symptoms when compared with the baseline scores.
Comparison of response of positive versus negative
symptoms did not show any significant difference.
Assessment of extra pyramidal symptoms using Simpson
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and Angus extra pyramidal symptoms rating scale showed
high incidence of rigidity (59%), tremor (32%), salivation
(30%), gait disturbance (25%) and akathisia (17%).
Anti Obsessional Drugs
Aggarwal and Aggarwal (2000) in an open trail lasting 12
weeks tested the usefulness of fluoxetine (80 mg/day) in
obsessive-compulsive symptoms in stabilized schizophrenic
patients. 5 out of 7 patients showed good response on Yales
Brown Obsessive Compulsive Symptoms Scale and the drug
was well tolerated.
b) Controlled / comparative trials
Atypical antipsychotics
Resperidone was reported to be better than haloperidol on
psychosocial functioning, productivity, education and
suicidality in an open randomized trial on 100 subjects with
diagnosis of schizophrenia (Srivastava & Gopa, 2000).
c) Double blind controlled studies
Centbutindole was reported to have an early onset of action
than haloperidol in one study (Singh et al., 1999).
d) Case reports / series
Case reports have reported on re-emergence of positive
symptoms in course of treatment with resperidone in
schizophrenia (Siva Prakash et al., 1999) and usefulness of
clozapine in childhood onset schizophrenia (Srinivasan and
Latha, 1997).Agarwal (1999) recommended augmentation
of clozapine with resperidone in patients who are non
responsive to clozapine alone. Srinivasan (1999)
recommended that clozapine in low doses could be an
effective and safe alternative to typical neuroleptics for
controlling severe psychiatric manifestations in dementia
patients.
B) Side Effects
Typical antipsychotics
Suresh Kumar and Manoj Kumar (1997) compared
retrospectively the neurological side effects in schizophrenia
patients and found that 70% had EPS or tardive dyskinesia.
54% had pseudoparkinsonism, 25% akathisia and 17% had
dystonias. Amongst specific side effects, NMS has been
most frequently reported. Few cases have been reported
in various case reports (Alexender et al., 1996; Sharma et
al., 1996 ; Das et al., 1997) Majority belonged to either sex,
were on high dose oral or depot neuroleptics alone or in
combination, had elevated CPK levels and responded to
conservative management or bromocriptine . Das et al.,
(1997) reported about a case with atypical resolution of
symptoms and proposed that there should be no stone
unturned in the quest for a comorbid condition alongside
NMS and systematic reports be made available regarding
symptom resolution in NMS with various treatment
modalities for better management. Few case reports on
rabbit syndrome (Pandey, 1998, Gada , 1997) due to
antipsychotics too have appeared .
Metochlopramide and levodopa have been reported to be
useful in reduction of tardive dyskinesia (Sethi et al., 1990).
Atypical antipsychotics
There have been few case reports on low thrombocytes
count during clozapine therapy (Savitharsi Eranti &
Chaturvedi, 1998;Tharyan, 1999). Case reports of
clozapine-induced agranulocytosis treated with Colony
Stimulatory Factor and Lithium (Srinivas & Thomas, 1998;
Jagdeesan et al., 2000) too have appeared. There has been
one case report each on epilepsy on clozapine therapy,
risperidone induced agranulocytosis and risperidone induced
NMS and dystonia (Prathima and Haque Nizamie, 1998;
Venkataswamy Reddy et al., 2000; Suresh Kumar, P.N.,
1999).Aggarwal and Khalid (1997) reported  three
schizophrenic patients who were resistant to typical
antipsychotics and developed obsessive-compulsive
symptoms during clozapine treatment. Khalid and Nepal
(2000) reported two cases of oculogyric crisis with
risperidone therapy.
ii) Electro convulsive therapy (ECT)
ECT was one of the first treatments tried for schizophrenia.
Presently, role of ECT in schizophrenia is rather limited. It
is used mainly for catatonic or affective symptoms and
patients with past history of good response. Not much of
research in to this area has been carried out in the last
decade.
Sarkar et al., (1994) concluded that ECT does not
meaningfully improve the response in unselected patients
of schizophreniform disorders treated with an adequate
dose of antipsychotic drug. In National symposium on ECT
in 1990 and a subsequent survey amongst members of IPS,
it was found that average number of ECT in schizophrenia
was 6.7 and mean maximum length was 11.5 weeks. In
the symposia, use of parentral diazepam as anaesthetic
agent and use of unmodified ECT was strongly discouraged
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(Aggarwal et al., 1992).
C) Kulhara (1998) reviewed the area of pharmacological
management of schizophrenia, outlining the management
strategies for “difficult to treat schizophrenia” and
emphasized on combined pharmacological and psychosocial
treatment of these patients.
VI. Psychosocial Variables and Psychosocial
management
Though recent developments in schizophrenia research has
brought the pharmacological options to fore, comprehensive
management of patients of schizophrenia relies heavily on
psychosocial treatment techniques. Various psychosocial
variables not only lead to variation in course and prognosis
of schizophrenia but also overall functioning of individual.
Moreover patients of schizophrenia, suffer from various
kinds of deficits, which need to be handled by psychosocial
means. In this aspect, role of family and society has been
increasingly brought to fore. Research in this area in India
is primarily descriptive. In following section, various studies
on psychosocial variables in last decade have been
addressed.
A. Disability
Disability is defined as any restriction in the ability to perform
an activity in a manner or within range considered normal
for a human being. Disability in schizophrenia is contributed
by symptoms, cognitive deficits and soft neurological signs
(Murthy, 1997). Researchers in India in last four decades
in this area focused attention on either modification/
development of scales for assessment of disability and
secondly evaluating the level of disability. In the last decade,
Padmavathi et al., (1995) developed SCARF Social
Functioning Index.
Follow - up studies on disability have reported that males
are more disabled than females in occupational functioning
(Thara & Joseph, 1995). Occupational dysfunction has been
reported to have maximum disability that was stable over 3
years period (Thara & Rajkumar, 1993). Schizophrenia with
better outcome has less disability with drug compliance being
the major factor behind reduction in disability (Thara &
Rajkumar, 1991).
In an effort to study management of disability, Thara et al.,
(1998) compared effect of medication alone as compared
to social skills training, family education and occupational
training on social disability. It was found that medication
alone group had better improvement in avolition, apathy,
anhedonia and asociality. Other group had more
improvement in areas of affective flattening, alogia and
attention deficits.
Murthy et al., (1994) concluded that non compliance leads
to increased disability.
B. Burden of care
Burden refers to the presence of problem, difficulties or
adverse events, which affect the lives of individuals who
are primary care givers. Various aspects of burden
addressed are financial, social discrimination, restriction of
social/ leisure activity and effect on health of others (Wig,
1997). While negative symptoms contributed maximally to
burden (Gopinath & Chaturvedi, 1992), Raj et al., (1991)
assessed social burden of positive and negative
schizophrenia.
Addlakha (1999) in an ethnographic study of family burden
and coping in schizophrenia demonstrated as how chronic
mental illness in a female member is managed by a lower
middle-class urban family. She argued that a general
hospital psychiatry unit might emerge as the only viable
option for periodic reprieves for both patients and families
in the absence of adequate and acceptable state-sponsored
facilities for long-term management of chronicity.
C. Coping Strategies
Understanding the way patients take care of their symptoms
is important, as a significant proportion of patients do not
respond to drugs satisfactorily. Moreover, it is important
because of the shifting trend to community care. Various
studies done on coping styles show that patients cope with
symptoms by intrapsychic and behavioural strategies
(Kumar et al., 1994; Kumar & Srinivasan, 1992).
Distraction, physical activities, social activities and cognitive
tasks are more frequently used strategies to cope with
symptoms by Indian patients (Raguram, 1993). Patients use
more coping strategies for subjective complaints than for
psychotic symptoms viz. delusion/hallucinations (Kumar et
al., 1994).
D. Quality Of Life (QOL)
QOL has been conceptualized as a multifaceted construct
that encompasses the individual’s behaviour and cognitive
capacities, emotional well being and abilities required for
the purpose of various domestic, vocational and social roles.
Murali et al., (1995) found that QOL was better in patients
who are occupied and literate. Background and marital
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status was not related to QOL Chaturvedi (1995) found
that QOL was better in paranoid schizophrenia but poor in
patients with negative symptoms. It was better in families
with low levels of distress. Gupta et al., (2000) found that it
is possible to apply Quality of Life Scale (QLS) in Indian
context.
E. Life events
There is dearth of work in this area from our country. Das
et al., (1997) and Kulhara et al., (1998) have reported about
relapse in schizophrenia and its relation to life events and
social support. Das et al., (1997) found that relapsing
schizophrenia had significantly more life events in the year
preceding relapse than stable or not relapsed patients.
However, this was not so just prior to relapse, rather events
occur in period 3-6 months before relapse.
OTHER ISSUES
A. Marriage
Marriage is implicated to be significant psychosocial variable
in schizophrenia. Thara & Srinivasan (1997) followed first
episode schizophrenia for 10 years and examined various
aspects related to marriage. 70% of patients had got
married. 90% of marriages were intact. Less men got
married and more women had broken marriages if they
had children. Relapses were more common with never
married people.
Kulhara et al., (1998) examined life events and social
support in 30 married and unmarried schizophrenia. Married
patient had more stress scores and undesirable life events
than unmarried patients. So married people appeared to
have more stress but other factors mitigated the risk of
relapse.
B. Expressed Emotions (EE)
Amongst various aspects of family interaction, an important
area of study has been expressed emotions. High EE has
been found to be related to relapse in schizophrenia. In
India, EE have been found to be significantly more in cities
than rural areas, though over all, far lower than developed
countries (Wig, 1997).
C. Rejection
Sam et al., (1998) conducted a study on 57 relatives (34
male and 23 female) of 57 (32 male and 25 female)
schizophrenic patients in Kerala in order to study their
rejection feelings towards their schizophrenic relatives. The
rejection response was found to be related to gender of
patients and relatives, being significantly higher in males.
Compared to the German and New York sample, the present
sample tends to have high rejection feeling.
Research on psychosocial issues in schizophrenia has been
largely at descriptive level only. There has been no
systematic research available on important issues of family
intervention, social skill training etc.
VII Course and Outcome of Schizophrenia:
Over the years, considerable amount of research work in
relation to course and outcome of schizophrenia has been
carried out in the West. The general consensus from these
studies indicates that about one third of patients recover,
one third continue to have chronic disability and another
one third have intermediate outcome. In preceding four
decades, number of studies were carried out in India to
assess the course and outcome in Indian patients and
compare those with non-Indian patients (such as
International Pilot Study of Schizophrenia, Determinants
of Outcome of Severe Mental Disorders etc.).These along
with few studies such as those sponsored by Indian Council
of Medical Research reached a broader consensus of a
relatively better outcome of schizophrenia in India as
compared to Western countries.
The follow up findings of International Pilot Study of
Schizophrenia at 5 years published in 1992 also reported
remarkably favourable outcome in Indian centers than
Western centers (Kulhara, 1997). In a 10 years long follow-
up of cohort of original ICMR collaborative study at Madras,
Thara et al., (1994, 1996) followed up 94 patients and found
that 11 patients had complete remission after initial episode,
2 had no relapse, but continued to have symptoms, 37 had
one or more relapse with complete remission, 21 had one
or more relapse with incomplete recovery and 5 had
continuous illness. Authors noted that there was a general
decline in both positive and negative symptoms in follow-
up.
Despite above significant findings, exact reasons for better
outcome of schizophrenia in developing countries remain
to be explored, though factors like low expressed emotions
have been implicated.
VIII Conclusions and Future Directions:-
Research on schizophrenia in India over the last decade
has encompassed almost all areas of relevance. While
epidemiological work has been able to highlight the extent
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of problem, cross-cultural differences in phenomenology
of schizophrenia is a significant finding. There have been
definite attempts at some biological research despite all
limitation due to paucity of facilities. Pharmacological
research, which without doubt has been replicative and
directionless, nonetheless is in keeping with the development
of newer drugs in this period. Though psychosocial aspects
of schizophrenia are increasingly under focus of research,
lack of any systematic work on psychosocial interventions
in schizophrenia is worth noting. Better prognosis of
schizophrenia in developing counters including India is well
documented. Unfortunately, if the quality of research in
this decade is compared with the last four decades, not
much progress seems to have been made. Research in
schizophrenia in India has been still without much structure
and organization. Multicentric, well-coordinated studies
using modern instruments are needed to arrive at a
consensual figure about prevalence and incidence of
schizophrenia with need to work on associated
epidemiological variables. There is a need to create nation
wide case registers, improve research facilities and creation
of better psychiatric centers for more meaningful research
into this area.
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